These results show that, in contrast to our previous findings in mesenchymal CMS4 SW480 CRC cells [15], inhibiting EZH2 activity in epithelial CMS3 HT29 cells had a minor effect on gene expression compared to PTEN KD. The gene discussed is EZH2; the disease is colorectal carcinoma.